Package 72516-018-06

{"route": ["ORAL"], "spl_id": "32c950ec-054d-b0f7-e063-6394a90ad41c", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0372516018061"], "unii": ["GLH0314RVC"], "rxcui": ["1116635"], "spl_set_id": ["32c950bd-7f5f-a811-e063-6394a90a0080"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Oryza Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "60 TABLET in 1 BOTTLE (72516-018-06)", "package_ndc": "72516-018-06", "marketing_start_date": "20250415"}], "brand_name": "Ticagrelor", "product_id": "72516-018_32c950ec-054d-b0f7-e063-6394a90ad41c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "72516-018", "generic_name": "Ticagrelor", "labeler_name": "Oryza Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208508", "marketing_category": "ANDA", "marketing_start_date": "20250415", "listing_expiration_date": "20261231"}